BAMF
MRNA icon

BI Asset Management Fondsmaeglerselskab’s Moderna MRNA Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,207
Closed -$33K – 749
2025
Q2 		$33K Sell
1,207
-15,365
-93% -$405K ﹤0.01% 711
2025
Q1 		$470K Buy
16,572
+168
+1% +$5.96K 0.01% 578
2024
Q4 		$682K Sell
16,404
-11,058
-40% -$529K 0.01% 584
2024
Q3 		$1.83M Sell
27,462
-30,877
-53% -$2.83M 0.03% 293
2024
Q2 		$6.93M Buy
58,339
+49,788
+582% +$6.3M 0.11% 161
2024
Q1 		$911K Sell
8,551
-56,986
-87% -$5.74M 0.02% 387
2023
Q4 		$6.52M Buy
65,537
+57,144
+681% +$4.81M 0.14% 144
2023
Q3 		$867K Sell
8,393
-2,036
-20% -$227K 0.02% 402
2023
Q2 		$1.27M Sell
10,429
-21,474
-67% -$2.86M 0.03% 320
2023
Q1 		$4.9M Buy
31,903
+23,665
+287% +$3.9M 0.13% 136
2022
Q4 		$1.48M Buy
8,238
+2,579
+46% +$422K 0.04% 266
2022
Q3 		$669K Sell
5,659
-1,767
-24% -$268K 0.03% 244
2022
Q2 		$1.06M Buy
7,426
+4,787
+181% +$684K 0.05% 222
2022
Q1 		$455K Buy
+2,639
New +$444K 0.02% 320
2020
Q4 		– Sell
-475
Closed -$34K – 452
2020
Q3 		$34K Buy
+475
New +$33.1K ﹤0.01% 448

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's MRNA Position: Q3 2025 in Review

BI Asset Management Fondsmaeglerselskab sold out of Moderna (MRNA) in Q3 2025, closing a stake of 1,207 shares — an estimated $33K sold.

BI Asset Management Fondsmaeglerselskab first reported a position in MRNA in Q3 2020 and held it in 15 quarters. The position peaked at $6.93M in Q2 2024. 644 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • BI Asset Management Fondsmaeglerselskab reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • BI Asset Management Fondsmaeglerselskab sold 1,207 Moderna shares in Q3 2025, an estimated $33K.
  • BI Asset Management Fondsmaeglerselskab first reported a position in Moderna in Q3 2020 and held it in 15 quarters.
  • BI Asset Management Fondsmaeglerselskab's Moderna position peaked at $6.93M in Q2 2024.
  • 644 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q3 2025, filed 5 Nov 2025.